Stay updated on Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.3%
    Check dated 2025-05-07T20:48:34.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new dates in April 2025 and a revision change from v2.15.0 to v2.15.2.
    Difference
    0.4%
    Check dated 2025-04-30T19:27:59.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-04-23T16:14:41.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new drug information related to Precursor Cell Lymphoblastic Leukemia-Lymphoma and the removal of detailed study descriptions for a trial involving daratumumab. The revision number has also been updated from v2.14.4 to v2.15.0.
    Difference
    22%
    Check dated 2025-04-16T13:24:20.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T06:50:21.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and the last update date has been changed to March 30, 2025, replacing the previous estimated date.
    Difference
    0.8%
    Check dated 2025-04-01T23:03:18.000Z thumbnail image

Stay in the know with updates to Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page.